| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000030961 |
| Receipt No. | R000035352 |
| Official scientific title of the study | A phase 2 study of choledochojejunostomy in pagients with locally advanced pancreatic adenocarcinoma undergoing chemo-proton therapy. |
| Date of disclosure of the study information | 2018/01/24 |
| Last modified on | 2018/01/23 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | A phase 2 study of choledochojejunostomy in pagients with locally advanced pancreatic adenocarcinoma undergoing chemo-proton therapy. | |
| Title of the study (Brief title) | Choledochojejunostomy for pancreatic adenocarcinoma undergoing chemo-proton therapy. | |
| Region |
|
|
| Condition | ||
| Condition | locally advanced pancreatic cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the efficacy and safety of choledochojejunostomy in patients with locally advanced pancreatic adenocarcinoma who are undergoing chemo-proton therapy. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | Phase II |
| Assessment | |
| Primary outcomes | Incidence of unplanned delay or discontinuation of proton therapy |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Historical |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Choledochojejunostomy before chemo-proton therapy | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Locally advanced pancreatic cancer 2. Malignant bile duct ostruction 3. Pathologically confirmed adenocarcinoma / adenosquamous carcinoma 4. Age: >=20,80< 5. Aerformance Status (ECOG) 0/1 6. Sufficient function of important organs 7. Written informed consent |
|||
| Key exclusion criteria | 1. Past history of choledochojejunostomy 2. History of diseases which cause bile duct stenosis 3. Past history of abdominal irradiation 4. Inability of solid oral intake 5. Uncontrollable diabetes mellitus 6. Sever complication(heart failure, renal failure,liver failure,intestinal paralysis etc) 7. Acute coronary syndrome within 6 months, severe arrythmia 8. Consistent steroid use 9. Severe mental disorder 10. doctors decision not to be registered to this study |
|||
| Target sample size | 50 | |||
| Research contact person | |
| Name of lead principal investigator | Hirochika Toyama |
| Organization | Kobe University |
| Division name | Division of Hepato-biliary-pancreatic Surgery Department of Surgery |
| Address | 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, Hyogo, Japan |
| TEL | 078-382-6302 |
| tymhr@me.com | |
| Public contact | |
| Name of contact person | Hirochika Toyama |
| Organization | Kobe University Graduate School of Medicine |
| Division name | Division of Hepato-biliary-pancreatic Surgery Department of Surgery |
| Address | 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, Hyogo, Japan |
| TEL | 078-382-6302 |
| Homepage URL | |
| tymhr@me.com | |
| Sponsor | |
| Institute | Kobe University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Self funding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035352 |